1. Home
  2. OSPN vs GOSS Comparison

OSPN vs GOSS Comparison

Compare OSPN & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSPN
  • GOSS
  • Stock Information
  • Founded
  • OSPN 1991
  • GOSS 2015
  • Country
  • OSPN United States
  • GOSS United States
  • Employees
  • OSPN N/A
  • GOSS N/A
  • Industry
  • OSPN EDP Services
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSPN Technology
  • GOSS Health Care
  • Exchange
  • OSPN Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • OSPN 597.9M
  • GOSS 586.6M
  • IPO Year
  • OSPN 1998
  • GOSS 2019
  • Fundamental
  • Price
  • OSPN $15.79
  • GOSS $2.99
  • Analyst Decision
  • OSPN Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • OSPN 3
  • GOSS 6
  • Target Price
  • OSPN $19.67
  • GOSS $8.60
  • AVG Volume (30 Days)
  • OSPN 447.2K
  • GOSS 4.6M
  • Earning Date
  • OSPN 10-29-2025
  • GOSS 11-06-2025
  • Dividend Yield
  • OSPN 3.07%
  • GOSS N/A
  • EPS Growth
  • OSPN 265.73
  • GOSS N/A
  • EPS
  • OSPN 1.53
  • GOSS N/A
  • Revenue
  • OSPN $240,621,000.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • OSPN $4.23
  • GOSS N/A
  • Revenue Next Year
  • OSPN $5.58
  • GOSS $30.65
  • P/E Ratio
  • OSPN $10.22
  • GOSS N/A
  • Revenue Growth
  • OSPN N/A
  • GOSS N/A
  • 52 Week Low
  • OSPN $12.51
  • GOSS $0.66
  • 52 Week High
  • OSPN $20.37
  • GOSS $3.60
  • Technical
  • Relative Strength Index (RSI)
  • OSPN 63.37
  • GOSS 59.87
  • Support Level
  • OSPN $15.27
  • GOSS $2.61
  • Resistance Level
  • OSPN $15.79
  • GOSS $3.60
  • Average True Range (ATR)
  • OSPN 0.35
  • GOSS 0.30
  • MACD
  • OSPN 0.09
  • GOSS 0.02
  • Stochastic Oscillator
  • OSPN 81.65
  • GOSS 50.20

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: